Tandem Diabetes Care, Inc.
NASDAQTandem Diabetes Care delivered one of the week's more dramatic squeeze setups — a heavily shorted stock that jumped 19% in a single session after earnings, leaving nearly 19% of the float still betting against it. The catalyst was Wednesday's Q2 print. The stock closed at $22.39 on Friday, up 15% on the week and 45% over the past month. That kind of velocity matters when 12.8…
TNDM short interest surges 34% in a week to 19% of float, driven by mounting bearish sentiment on earnings disappointment and competitive headwinds.
Tandem Diabetes Care delivered one of the week's more dramatic squeeze setups — a heavily shorted stock that jumped 19% in a single session after earnings, leaving nearly 19% of the float still betting against it. The…
Tandem Diabetes Care reports first-quarter results on May 20 with the stock deep in a drawdown — down 39% over the past month and 17% in the past week alone to close at $12.82. The damage follows a punishing Q4-style…
Snapshot as of 8 Aug 2026
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TNDM — free to start on ORTEX.
Sign up for free →Open TNDM on ORTEX